A Phase II, Open-label Study Improving Compliance and Time of Treatment After Obtaining Complete Response Through a Tailored Schedule of Sonidegib in Locally Advanced Basal Cell Carcinomas (BCC) - the SONIBEC Trial
Latest Information Update: 23 Mar 2021
At a glance
- Drugs Sonidegib (Primary)
- Indications Basal cell cancer
- Focus Therapeutic Use
- Acronyms SONIBEC
Most Recent Events
- 10 Dec 2020 New trial record